AI assistant
KALA BIO, Inc. — Director's Dealing 2025
Jun 27, 2025
35091_dirs_2025-06-26_35219c90-99a9-4241-a846-ec3ece3a4fb4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KALA BIO, Inc. (KALA)
CIK: 0001479419
Period of Report: 2025-06-24
Reporting Person: Bazemore Todd (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-24 | Common Stock | S | 4058 | $4.01 | Disposed | 83699 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1 | Indirect |
Footnotes
F1: This sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 10, 2020 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's restricted stock units ("RSUs") granted on June 22, 2023.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.87 to $4.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F3: Includes 35,732 unvested RSUs.